Zpráva o průběhu klinického hodnocení Annual Report KDO_DC1311 za období 10. září 2022 ‒ 9. září 2023

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Progress Report of the clinical evaluation Annual Report KDO_DC1311 for the period September 10, 2022 - September 9, 2023
Authors	DEMLOVÁ Regina KUBÁTOVÁ Jana
Year of publication	2023
MU Faculty or unit	Faculty of Medicine
Web	KDO_DC1311
Description	The annual report gives the overview of the conduct of the clinical trial „Combined antitumor therapy with ex vivo manipulated dendritic cells producing interleukin-12 in children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors“. The primary aim of the clinical trial is to study the safety of inovative medicinal product of somatic cell therapy. Masaryk University is the trial sponsor.
Related projects:	CZECRIN - Czech National Node to the European Clinical Research Infrastructure Network